1. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment. Issue 19 (12th April 2019) Authors: Fu, Xin; Liang, Qing-rong; Luo, Rong-guang; Li, Yan-shu; Xiao, Xiao-ping; Yu, Lu-lu; Shan, Wen-zhe; Fan, Guang-qin; Tang, Qun Journal: Journal of materials chemistry Issue: Volume 7:Issue 19(2019) Page Start: 3088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of colloidal rare-earth arsenites as arsenic trioxide nanoparticle prodrugs (ATONP) for chemotherapy on a patient-derived xenograft model of colorectal cancer. (31st October 2019) Authors: Fu, Xin; Zhang, Hua-qing; Zhao, Jun; Yu, Lu-lu; Liang, Qing-rong; Zhang, Yu; Yi, Xiu-Guang; Li, Yong-xiu; Hu, Ji-long; He, Yuan-qiao; Tang, Qun Journal: New journal of chemistry Issue: Volume 43:Number 44(2019) Page Start: 17408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗